1/41
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
ADME phases:
absorption, distribution, metabolism and excretion
AMDET includes toxicology
pharmacokinetics
reasons for conducting ADME
predicting if correct properties for use eg dosing frequency
determining initial dose
determining if drug like properties
drug like properties
structural
hydrogen bonding, polar surface area, lipophilicity, shape, MW, reactivity, pKa
physiochemical
solubility, permeability, chemical stability
biochemical
metabolism, protein and tissue binding, transport
PK and toxicity
clearance, half life, bio
Which drug discovery stages is ADME implemented in?
target identification
hit identification
lead identification
lead optimisation
What are exceptions to the lipinskis rule of 5 for good absorption/permeation?
substrates for membrane transporters
why is solubility of drugs important
drugs must be in solution before absorption can occur
movement of unchanged drug from site of administration to systemic circulation is crucial for absorption
low lipid solubility = poor absorption = low oral bioavailability
bioavailability (F) definition and equation
fraction of administered dose which reaches the systemic circulation and is active at intended drug site
F = AUCroute / AUC IV
which route has the highest bioavailability ?
IV route
F=1
examples of physiological barriers which impact bioavailability
liver
blood brain barrier
intestinal mucosa
explain the low availability from the stomach and liver
Ø parietal cells secrete HCl
Ø chief cells secrete digestive enzymes
Ø presystemic extraction by the enterocytes and/or liver
Ø efflux by P-glycoprotein
p glycoprotein
ABC transporter superfamily
responsible for multi drug resistance in cancer cells
where is p glycoprotein found
in high concentrations of apical surface of epithelial cells in intestine, liver, kidney and BBB
transport across the intestinal mucosa depends on what factors?
size, charge, lipid solubility, concentration gradient
ABC transporters
involved in active transport
contains nucleotide binding domains and transmembrane domains
partition coefficient - P definition and equation
measure drugs lipid solubility
indicates ability of drug to cross cell membrane
P = concentration in organic solvent / concentration in aqueous
P values indicate what
lipid solubility
P > 1 - lipophillic
P < 1 - hydrophilic
in vitro permeability methods
cell based - caco-2 cell layer method
cell free permeation methods - IAM HPLC, PAMPA
organoids
in silico
where does the highest absorption occur and why
small intestine rather than the stomach
due to increased surface area
caco-2 cell layer method
prepare human cell line of colon
drug molecules are added to apical side
measure the time and concentration of molecules which are absorbed across the caco-2 cells to the basolateral side
advantages of caco-2 cell layer method
can measure passive diffusion, active and efflux
good prediction of absorption
has microvilli + p-glycoprotein
limitations of caco-2 and alternatives
expensive
cell free permeation methods - IAM HPLC, PAMPA
but can only mimic passive diffusion
define distribution
reversible transfer of drug between blood and various tissues
what factors affect the extent of distribution
molecular size
lipid solubility
pH partitioning
tissue perfusion
protein binding
tissue binding
capillary permeability
disease state
drug formulation
problems if large molecular size
poor absorption and distribution
remains in the vasculature
Describe the relationship between particle size of a compound and its oral bioavailability. (1 mark)
larger the particle size
the less the bioavailability
perfusion of tissues and accumulation relationship
highly perfused tissues accumulate drugs more rapidly
leads to higher Vd
order of tissue perfusion from highest to lowest
lung
kidney
liver
heart
gi tract
brain
adipose
apparent volume distribution Vd
hypothetical volume that would contain the total body content of the drug Q
at a concentration equal to that present in the plasma at steady state
relates the amount of drug in the body to the blood concentration
calculation for apparent volume of distribution Vd


how to calculate Vd from a graph
extrapolate to find C0 before elimination
dose / this value
make sure units are in L
plasma protein binding and Vd. give relationship and example
warfarin has a lower Vd because it is tightly bound to plasma proteins rather than tissues
lower the Vd less binding of drug molecules to tissues and more to plasma proteins
what factors does Vd depend on
–binding of drug molecules to plasma proteins (Vd is low)
–binding of drug molecules to tissues (Vd is higher), e.g. **more lipid soluble drugs
Vd size and [blood]
drugs with small Vd will achieve larger [blood]
drugs with large Vd will achieve lower [blood]
first pass mechanism
30% will be absorbed into enterocyte uptake
this is due to gut lumen and intestinal metabolism
portal vein to liver then 15% will make it into the systemic exposure
CYP450 metabolism
How do drug molecules move around the body?
bulk flow (i.e. in the bloodstream, lymphatics or cerebrospinal fluid, or during passage through the gastrointestinal tract)
diffusion (i.e. molecule by molecule, over short distances).
3 main ways (+1) small molecules cross cell membranes
by diffusing directly through the lipid;
by combination with a solute carrier (SLC) or other membrane transporter;
by diffusing through aqueous pores formed by special membrane glycoproteins ( aquaporins ) that traverse the lipid;
further, small quantities of macromolecules may cross cell barriers by pinocytosis – ‘cell drinking’
ion trapping
ionisation and permeability affect rate of absorption and distribution
ions will accumulate across membrane due to differences in pH and ion charge
quantified by fura-2
why do large ion gradients not reach theoretical values
small permeability changes will have big effect on conc
body compartments rarely reach equib
bulk flow reduces conc gradeints below theoretical values
pH and accumulation
weak acids accumulate with areas of high pH
weak bases do the reverse
What does amount of drug bound to protein depend on
the concentration of free drug
its affinity for the binding sites
the concentration of protein
Which of the following has the most impact on the bioavailability of a small molecule drug?
A.Displacement of plasma protein binding by competing drugs
B.The partition coefficient of the drug
C.Its rate of diffusion through aqueous pores
D.The diffusion coefficient of the drug
E.The pH of the compartment
B
Which of the following is NOT a major factor of consideration when choosing the most effective route of administration of a drug?
D
occurs irrespective of initial route of administration